Deal facts
- Buyer
- INVESTINDUSTRIAL
- Target
- DCC HEALTHCARE
- Deal value
- Not disclosed
- Announced
- 14 July 2025
- Status
- In review
- Sector
- Healthcare
- Country
- Not stated
- Consideration
- Not stated
Sources
INVESTINDUSTRIAL has agreed to acquire DCC Healthcare in a transaction announced on 14 July 2025. The deal involves entities operating within the pharmaceutical and medical equipment sectors, classified under NaceV2Sector codes C.21 and C.32.5. No specific financial consideration or deal value was disclosed in the available information regarding this acquisition. The transaction structure remains undefined as the deal type is currently unknown, and the target country has not been reported.
The acquisition is currently subject to regulatory review as the last recorded status is in review. Completion of the transaction has not yet occurred as no completion date has been confirmed. Further details regarding the specific terms of the agreement or the strategic rationale behind the purchase have not been made public. Investors and market observers await the outcome of the ongoing regulatory assessment before the deal can proceed to finalisation. The transaction is subject to regulatory approval.
Weekly digest
Join Exit Mode Insider
Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.
Join Exit Mode Insider, £12/moDeal timeline
1 update- CMA invitation to comment
INVESTINDUSTRIAL to acquire DCC HEALTHCARE
INVESTINDUSTRIAL to acquire DCC HEALTHCARE
EU DG COMP
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
KOHLBERG / MONTAGU to acquire TELEFLEX OEM BUSINESS
KOHLBERG / MONTAGU has agreed to acquire the TELEFLEX OEM Business in a transaction announced on 22 March 2026. The deal involves a company operating within the NaceV2Se…
- Buyer
- KOHLBERG / MONTAGU
- Target
- TELEFLEX OEM BUSINESS
- Deal value
- Not disclosed
- Deal type
- unknown
SK CAPITAL to acquire SWIXX BIOPHARMA
SK CAPITAL has agreed to acquire SWIXX BIOPHARMA in a transaction announced on 8 March 2026. The deal involves the biopharmaceutical sector, specifically within the whol…
- Buyer
- SK CAPITAL
- Target
- SWIXX BIOPHARMA
- Deal value
- Not disclosed
- Deal type
- unknown
EQT to acquire Oxford Biomedica plc
EQT has agreed to acquire Oxford Biomedica plc, a UK-based CDMO and viral vector specialist, in a transaction announced on 25 February 2026. The specific financial terms…
- Buyer
- EQT
- Target
- Oxford Biomedica plc
- Deal value
- Not disclosed
- Deal type
- unknown
GTCR to acquire ZENTIVA
GTCR has agreed to acquire ZENTIVA in a transaction announced on 19 February 2026. The deal involves the pharmaceutical sector, classified under NaceV2Sector_C_21. No fi…
- Buyer
- GTCR
- Target
- ZENTIVA
- Deal value
- Not disclosed
- Deal type
- unknown
WARBURG PINCUS to acquire SEBIA
WARBURG PINCUS has agreed to acquire SEBIA in a transaction announced on 12 November 2025. The deal involves a company operating across multiple industrial sectors, incl…
- Buyer
- WARBURG PINCUS
- Target
- SEBIA
- Deal value
- Not disclosed
- Deal type
- unknown
Buyer history
INVESTINDUSTRIAL
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive
